clopidogrel hydrogen sulfate
ItalyDrugs containing this active substance
-
It is used by adults to prevent the formation of blood clots (thrombi) in hardened arteries, reducing the risk of serious events such as stroke, heart attack, or death. It is indicated for those with atherosclerosis, those who have had a heart attack or stroke, those suffering from unstable angina or peripheral artery disease, or those with an irregular heartbeat (atrial fibrillation).
Form: tablets, film-coated
Active substance Dosage clopidogrel hydrogen sulfate - ATC: B01AC04
Manufacturer: ALMUS S.R.L.
-
It is prescribed to adults to prevent the formation of blood clots in hardened arteries, reducing the risk of events such as stroke, heart attack, or death. It is indicated for those who have suffered from unstable angina or myocardial infarction, even if a stent has been placed.
Form: tablets, film-coated
Active substance Dosage clopidogrel hydrogen sulfate - acetylsalicylic acid - ATC: B01AC30
Manufacturer: DOC GENERICI SRL
-
It is prescribed to prevent the formation of blood clots (thrombi) in hardened arteries, reducing the risk of serious events such as stroke, heart attack, or death. It is indicated for adults with atherosclerosis who have had a heart attack, stroke, unstable angina, peripheral artery disease, or atrial fibrillation (when they cannot take other types of anticoagulants).
Form: tablets, film-coated
Active substance Dosage clopidogrel hydrogen sulfate - ATC: B01AC04
Manufacturer: EG S.P.A.
-
It is used by adults to prevent the formation of blood clots (thrombi) in hardened arteries, reducing the risk of serious events such as stroke, heart attack, or death. It is indicated for those with atherosclerosis, who have had a heart attack or stroke, or who suffer from unstable angina, peripheral artery disease, or atrial fibrillation.
Form: tablets, film-coated
Active substance Dosage clopidogrel hydrogen sulfate - ATC: B01AC04
Manufacturer: SANOFI WINTHROP INDUSTRIE
-
It is used by adults to prevent the formation of blood clots (thrombi) in hardened arteries, reducing the risk of serious events such as stroke, heart attack, or death. It is prescribed to those with atherosclerosis, who have had a heart attack or stroke, or who suffer from unstable angina, peripheral artery disease, or atrial fibrillation.
Form: tablets, film-coated
Active substance Dosage clopidogrel hydrogen sulfate - ATC: B01AC04
Manufacturer: SANOFI WINTHROP INDUSTRIE